HIF1A and renal cell carcinoma: Geldanamycin and tanespimycin Geldanamycin, an inhibitor of Hsp90, has been shown to promote the ubiquitination and subsequent proteasomal degradation of HIF-1α in RCC cells, regardless of oxygen levels [258].